Ketalar side effects, by duration, gender and age (a phase IV clinical study of FDA data)
Summary:
Side effects are reported by people who take Ketalar (ketamine hydrochloride). Common side effects include dilatation intrahepatic duct acquired among females and accidental death among males.
The phase IV clinical study is created by eHealthMe based on 1,219 reports from the FDA, and is updated regularly.
What is Ketalar?
Ketalar has active ingredients of ketamine hydrochloride. eHealthMe is studying from 1,226 Ketalar users. Check the latest studies of Ketalar.
1,219 people who take Ketalar and have side effects are studied.
What are the common side effects of Ketalar, by gender? *
What are the common side effects of Ketalar, by age (0-1 to 60+)? *
What are the common side effects of Ketalar, by the time people have been on the drug (< 1 month to 10+ years)? *
* Approximation only. Some reports may have incomplete information.
Do you take Ketalar?
- Personalize this study to your gender and age- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
How the study uses the data?
The study is based on ketamine hydrochloride (the active ingredients of Ketalar) and Ketalar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies are listed below in case you need more information:
Alternative drugs to, pros and cons of Ketalar:
- Ketalar (1,226 reports)
All Ketalar side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Proventil and Mycelex - 14 seconds ago
- Could Patanol cause Intestinal Obstruction? - 18 seconds ago
- Could Focalin cause Urticaria? - 19 seconds ago
- Could Cialis cause Penis Disorder? - 20 seconds ago
- Could Gonal-F cause Vaginal Bleeding? - 28 seconds ago
- Drug interactions of Meloxicam and Zebeta - 29 seconds ago
- Hyperglycemia and drugs of ingredients of panitumumab - 33 seconds ago
- Arrhythmias in Metoprolol Succinate, how severe and when it was recovered? - 35 seconds ago
- Imodium and Zolpidem Tartrate drug interactions for men aged 60+ - 37 seconds ago
- Could Eliquis cause Hyperkeratosis? - 47 seconds ago